Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III–IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial
Gan, Jing, Wu, Yansheng, Gong, Xuezhong, Ma, Yiyi, Yu, Shengqiang, Gao, JiandongVolume:
20
Langue:
english
Journal:
Trials
DOI:
10.1186/s13063-019-3563-5
Date:
December, 2019
Fichier:
PDF, 784 KB
english, 2019